Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TEK | Q02763 | 14/20 | 0.81 |
| ▸ | KDR | P35968 | 10/20 | 0.75 |
| ▸ | AURKB | Q96GD4 | 11/20 | 0.58 |
| ▸ | AURKA | O14965 | 10/20 | 0.58 |
| ▸ | TPX2 | Q9ULW0 | 6/20 | 0.58 |
| ▸ | LCK | P06239 | 5/20 | 0.57 |
| ▸ | ABL1 | P00519 | 1/20 | 0.55 |
| ▸ | CSF1R | P07333 | 1/20 | 0.55 |
| ▸ | KIT | P10721 | 1/20 | 0.55 |
| ▸ | SRC | P12931 | 1/20 | 0.55 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL974421 | 0.90 | TEK (0.76) | TEKKDRAURKBAURKATPX2 | |
| SCHEMBL974466 | 0.90 | TEK (1.00) | TEKKDRAURKBAURKATPX2 | |
| SCHEMBL973160 | 0.88 | TEK (0.73) | TEKKDRAURKBAURKATPX2 | |
| SCHEMBL974898 | 0.86 | TEK (0.84) | TEKKDRAURKBAURKATPX2 | |
| SCHEMBL973142 | 0.85 | TEK (0.80) | TEKKDRAURKBAURKATPX2 | |
| SCHEMBL972342 | 0.85 | TEK (1.00) | TEKKDRAURKBAURKALCK | |
| SCHEMBL974106 | 0.85 | TEK (0.81) | TEKKDRAURKBAURKATPX2 | |
| SCHEMBL974171 | 0.83 | TEK (0.75) | TEKKDRAURKBAURKATPX2 | |
| SCHEMBL975976 | 0.83 | TEK (0.88) | TEKKDRAURKBAURKATPX2 | |
| SCHEMBL972047 | 0.81 | TEK (0.72) | TEKKDRAURKBAURKATPX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7868177-B2 | Multi-cyclic compounds and method of use | AMGEN INC. (US) | 2011-01-11 | — | — | US | claimed |
| EP-1994030-B1 | MULTI-CYCLIC COMPOUNDS AND METHOD OF USE | AMGEN INC (US) | 2010-08-25 | — | — | EP | disclosed |